MARKET

BFRGW

BFRGW

Bullfrog AI Holdings, Inc.
NASDAQ
0.1400
-0.0110
-7.28%
Closed 15:44 06/05 EDT
OPEN
0.1700
PREV CLOSE
0.1510
HIGH
0.1700
LOW
0.1400
VOLUME
480
TURNOVER
--
52 WEEK HIGH
0.8537
52 WEEK LOW
0.1000
MARKET CAP
--
P/E (TTM)
-0.2546
1D
5D
1M
3M
1Y
5Y
1D
President Trump Says Meeting Scheduled With AI Companies Soon; They Are Coming To White House, Maybe Next Week
Benzinga · 8h ago
BullFrog AI names John Stewart SVP commercial sales to lead growth push
PUBT · 3d ago
Press Release: BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
Dow Jones · 3d ago
Weekly Report: what happened at BFRG last week (0525-0529)?
Weekly Report · 4d ago
BULLFROG AI - LINCOLN PARK CAPITAL FUND MAY RESELL UP TO 2 MLN SHARES - SEC FILING
Reuters · 05/29 20:35
Weekly Report: what happened at BFRG last week (0518-0522)?
Weekly Report · 05/25 10:36
Weekly Report: what happened at BFRG last week (0511-0515)?
Weekly Report · 05/18 10:36
Axios Reported More Than 60 Trump Allies Urge President To Test And Approve Most Powerful AI Models Before Release
Benzinga · 05/18 09:23
More
About BFRGW
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Webull offers Bullfrog AI Holdings, Inc. stock information, including NASDAQ: BFRGW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRGW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRGW stock methods without spending real money on the virtual paper trading platform.